ArticleOncotarget2017

Increased PDGFR-beta and VEGFR-2 protein levels are associated with resistance to platinum-based chemotherapy and adverse outcome of ovarian cancer patients.

Stefanie Avril et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.